Ryan Mee, CEO of Fulcrum Metals, reviews FY23 and progress on the Gold Tailings Hub in Canada. Watch the video here.
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
I suspect the rise this week is going to be inspired by US contract to come with numbers expected.
This, whilst constrained will be secondary.
Yes, GDR too , Genedrive also been signed up. govt seem to be sidelining NCYT now. or at least playing hardball with them. still no meat on the bone yet. figures needed aimho.
Not sure how many others have a quality pcr test plus lab facilities all in a one stop shop.
Hallo Twix, How would you reword the RNS then? Bearing in mind the other 111 participants.
Watch for the inevitable spike - This has happened numerous times with ODX over the last few months on any promise of news - traders in and out for the day.
To reassure Twix - there were never going to be any numbers - the government can't be accountable for this - too easy!
Have a good week everyone
Dan
GDR got one today too, see their RNS.
They are just confirming they are in the race. Numbrts will follow no doubt. I see gdr have announced similar.
Spot on Twix - hard not to be underwhelmed with this.
Ok twix oracle, you’ve expressed your predictable views on both sites. Now please jog on for the day and continue your research on the next crash in the bubble of your spare bedroom. I thank you, irritant-in-chief.
Never let it be said that there's news we can't underplay without fanfare and with every caveat we can muster.
Hmmmm good news but wooly with no detail other than the opportunity to get business though nothing guaranteed.
Good but typically the usual situation where delivery misses expectation.
Let's see where the share price goes. Should be higher of course but my view is more muted.
Manchester, UK - 19 April 2021: Yourgene (AIM: YGEN), the international molecular diagnostics group, announces that it has been awarded a Framework Agreement under Public Health England's ("PHE") National Microbiology Framework for Lot 1 (Diagnostic Goods and Services) of the four-lot tender for its Clarigene® SARS-CoV-2 assay and Manchester-based COVID testing service.
PHE's National Microbiology Framework is appointing suppliers to framework agreements for four lots. Lot 1 is the first to be announced and covers the supply of in-vitro diagnostic medical devices and associated services, including for the Company's Clarigene® SARS-CoV-2 PCR assay and the associated clinical laboratory testing services delivered through Yourgene Genomic Services. The term of the Framework Agreement for Lot 1 (and for each subsequent lot, if awarded) is for an initial two years with options to extend by up to a further two years. Lot 1 is a £3bn tender to be satisfied by multiple successful bidders.
Under the National Microbiology Framework, participating public health authorities across the United Kingdom can use call-off contracts to procure goods and testing services from Yourgene under such lots as it is in receipt of a Framework Agreement, but there is no guarantee that such contracts will be forthcoming, nor as to the quantum of any potential call-off contracts may which arise.
Lyn Rees, CEO of Yourgene commented:
"We welcome the opportunity to work with PHE and its sister organisations across the NHS, DHSC and in Wales, Scotland and Northern Ireland to offer our Clarigene® SARS-CoV-2 PCR assay, and our accredited lab testing services, to contain Covid-19 in the near-term and to participate in putting in place a robust testing infrastructure post-pandemic. Yourgene considers that the successful framework award, for which there was a competitive tender process, lends significant credibility to the Clarigene® product and to the Company's COVID testing services. More broadly, we expect the award to support business development outside the scope of this agreement with a growing network of commercial partners, addressing privately funded testing in healthcare and workplace settings."